Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Allylbenzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB known ✓ | P27338 | 1/20 | 0.48 |
| ▸ | SLC18A2 known ✓ | Q05940 | 1/20 | 0.39 |
| ▸ | SIGMAR1 known ✓ | Q99720 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 1/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.47 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.47 |
| ▸ | CNR2 | P34972 | 1/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.42 |
| ▸ | CALM1 | P0DP23 | 1/20 | 0.42 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Allylbenzene SCHEMBL28162046 | 0.98 | CYP3A4 (0.46) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL18550554 | 0.98 | MAOB (0.50) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL28033453 | 0.91 | MAOB (0.57) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL5697714 | 0.91 | MAOB (0.57) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL1648511 | 0.88 | MAOB (0.50) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL5940129 | 0.88 | MAOB (0.55) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL28198945 | 0.88 | MAOB (0.55) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL21274 | 0.88 | — | — | |
| Allylbenzene SCHEMBL2478260 | 0.88 | MAOB (0.60) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 | |
| Allylbenzene SCHEMBL10325179 | 0.88 | MAOB (0.60) | CYP3A4KDM4EMAPTMAOBSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 218 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230305412-A1 | TONER, TONER PRODUCTION METHOD, TONER STORAGE UNIT, IMAGE FORMING APPARATUS, AND IMAGE FORMING METHOD | RICOH COMPANY, LTD (JP) | 2023-09-28 | — | — | US | disclosed |
| US-20230273540-A1 | TONER | CANON KABUSHIKI KAISHA (JP) | 2023-08-31 | — | — | US | disclosed |
| US-20230258922-A1 | DISPLAY APPARATUS AND INITIAL SETTING METHOD FOR DISPLAY APPARATUS | Sony Group Corporation (JP) | 2023-08-17 | — | — | US | disclosed |
| US-11656459-B2 | Display apparatus with a glasses type frame and an image display device | SONY CORPORATION (JP) | 2023-05-23 | — | — | US | disclosed |
| CN-115453833-A | Toner and image forming apparatus | 佳能株式会社 | 2022-12-09 | — | — | CN | disclosed |
| CN-107239015-B | Carrier for two-component developer, and method for producing carrier | 富士胶片商业创新有限公司 | 2022-11-01 | — | — | CN | disclosed |
| EP-4011980-A1 | ORGANOHYDROGEN POLYSILOXANE EMULSION AND ADDITION-CURABLE SILICONE EMULSION COMPOSITION USING SAME | Shin-Etsu Chemical Co., Ltd. (JP) | 2022-06-15 | — | — | EP | disclosed |
| US-11333878-B2 | Display apparatus and initial setting method for display apparatus | SONY CORPORATION (JP) | 2022-05-17 | — | — | US | disclosed |
| CN-114442446-A | Toner and image forming apparatus | 佳能株式会社 | 2022-05-06 | — | — | CN | disclosed |
| US-11112714-B2 | Toner | CANON KABUSHIKI KAISHA (JP) | 2021-09-07 | — | — | US | disclosed |
| US-5998078-A | Method of preparing toner for electrostatic charge image development, toner for electrostatic charge image development, electrostatic charge image developer, and image forming method | FUJI XEROX CO., LTD. (JP) | 1999-12-07 | — | — | US | disclosed |
| EP-0573978-B1 | Bath additive composition comprising surfactant-containing seamless capsules and method for producing the capsules. | KAO CORP (JP) | 1999-04-21 | — | — | EP | disclosed |
| US-5888687-A | AGGREGATION OF PARTICLES IN RESIN DISPERSION | FUJI XEROX CO., LTD. (JP) | 1999-03-30 | — | — | US | disclosed |
| US-5849456-A | Toner for developing electrostatic charge image, production method thereof, and image formation method | FUJI XEROX CO., LTD. (JP) | 1998-12-15 | — | — | US | disclosed |
| US-5607910-A | HEXAGONAL LIQUID CRYSTAL PHASE | PROCTER & GAMBLE COMPANY | 1997-03-04 | — | — | US | disclosed |
| US-5385737-A | Comprising an inner layer and a film outer layer, inner layer having a liquid of an oily component and nonionic surfactant excellent in emulsification and dispersion in water | KAO CORPORATION (JP) | 1995-01-31 | — | — | US | disclosed |
| EP-0573978-A1 | Surfactant-containing seamless capsules | KAO CORPORATION (JP) | 1993-12-15 | — | — | EP | disclosed |
| EP-0153857-B1 | DETERGENT COMPOSITIONS | UNILEVER N.V. (NL) | 1988-09-21 | — | — | EP | disclosed |
| US-4615819-A | SULFONATES, SULFOSUCCINATES, ETHER SULFATES, UREA, BUILDERS-DISHES AND FABRICS | LEVER BROTHERS COMPANY (US) | 1986-10-07 | — | — | US | disclosed |
| EP-0153857-A2 | Detergent compositions | UNILEVER N.V. (NL) | 1985-09-04 | — | — | EP | disclosed |